Genocea Biosciences, Inc.
Total raised
$153 M
4 rounds on record
Latest round
$76 M
Jul 2020
First round on record
Dec 2010
Today
Private
No later event on record
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Genocea Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2020).
SEC Form D · Aug 2020
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Aug 2020
Products and services#
No products or services on record: its website does not allow automated readers.
Investors#
13 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| GSK PLC | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Johnson & Johnson Development Corp Et Al | Company | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Capital Management, LLC | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Venture Associates II, LLC | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Venture Partners II, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Ventures II, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Ventures II Sidecar II LLC | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Lux Ventures II Sidecar LP | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Management Co. V, L.L.C. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners V, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Diantha Duvall | Executive officer | Aug 2020 |
| Girish Aakalu | Executive officer | Aug 2020 |
| Jessica Flechtner | Executive officer | Aug 2020 |
| Thomas Davis | Executive officer | Aug 2020 |
| William Clark | Executive officer | Aug 2020 |
| Derek Meisner | Executive officer | Feb 2019 |
| Michael Alfieri | Executive officer | Feb 2019 |
| Narinder Singh | Executive officer | Feb 2019 |
| Pamela Carroll | Executive officer | Feb 2019 |
| Jessica Baker Flechtner | Executive officer | Jul 2013 |
| Paul Baker Giannasca | Executive officer | Jul 2013 |
| Ravi Baker Venkataramani | Executive officer | Jul 2013 |
| Robert E. Farrell Jr. | Executive officer | Jul 2013 |
| Seth Baker Hetherington | Executive officer | Jul 2013 |
| William Baker Clark | Executive officer | Jul 2013 |
| Dalton Einhorn | Executive officer | Jan 2011 |
| Robert Farrell Jr. | Executive officer | Jan 2011 |
| Ali Behbahani | Director | Aug 2020 |
| George Siber | Director | Aug 2020 |
| Gisela Schwab | Director | Aug 2020 |
| Howard Mayer | Director | Aug 2020 |
| Katrine Bosley | Director | Aug 2020 |
| Kenneth Bate | Director | Aug 2020 |
| Michael Higgins | Director | Aug 2020 |
| Ronald Cooper | Director | Aug 2020 |
| Asish Xavier | Director | Jul 2013 |
| Kevin Bitterman | Director | Jul 2013 |
| Robert Paull | Director | Jul 2013 |
| Simeon George | Director | Jul 2013 |
| Stephen Hoffman | Director | Jul 2013 |
| William Baker Clark | Director | Jul 2013 |
| Leon Chen | Director | Oct 2012 |
| Dalton Einhorn | Director | Jan 2011 |
| Steve Hoffman | Director | Jan 2011 |
About
Company in Cambridge, United States.